calendar
8,031 catalysts · 5,347 phase readout · 2,338 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom
next 91 dayslessmore
MonWedFri
8,031 catalysts · 5,347 phase readout · 2,338 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom
Sponsor: University Hospital, Brest. Phase: NA. Conditions: Anterior Cruciate Ligament Rupture With Ligamentoplasty
Sponsor: National and Kapodistrian University of Athens. Phase: . Conditions: Haemorrhoid, Haemorrhoidal Bleeding, Anorectal Surgeries, Anorectal Diseases
Sponsor: Mario Castro, MD, MPH. Phase: PHASE1. Conditions: Asthma, COPD, Interstitial Lung Disease, Cystic Fibrosis, Pulmonary Hypertension, Pulmonary Infection, Other Lung Disease
Sponsor: Washington University School of Medicine. Phase: PHASE2. Conditions: Alzheimer Disease, Early Onset, Mild Cognitive Impairment
Sponsor: Beijing Anzhen Hospital. Phase: PHASE3. Conditions: Aortic Stenosis, Calcific
Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Malignant Solid Neoplasm
Sponsor: Efforia, Inc. Phase: NA. Conditions: Insulin
Sponsor: Henan Cancer Hospital. Phase: PHASE2. Conditions: Metastatic Breast Cancer
Sponsor: Rutgers, The State University of New Jersey. Phase: NA. Conditions: Code Status Discussions With Medical In-patients
Sponsor: Hospices Civils de Lyon. Phase: NA. Conditions: Penile Prosthesis
Sponsor: University of Edinburgh. Phase: . Conditions: Angina, Stable, Coronary Artery Disease
Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences. Phase: NA. Conditions: Non-erosive Reflux Disease (NERD)
Sponsor: Lomonosov Moscow State University Medical Research and Educational Center. Phase: PHASE2. Conditions: Erectile Dysfunction Due to Arterial Disease, Atheroscleroses, Erectile Disfunction, Endothelial Dysfunction, Androgen Profile, Testosterone
Sponsor: Metsera, a wholly owned subsidiary of Pfizer. Phase: PHASE2. Conditions: Obesity, Overweight or Obesity
Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Type 2 Diabetes
Sponsor: Abalos Therapeutics GmbH. Phase: PHASE1. Conditions: Advanced Solid Tumors
Sponsor: Assiut University. Phase: . Conditions: Diabetic Nephropathy, Dyslipidemia
Sponsor: Brigham and Women's Hospital. Phase: EARLY_PHASE1. Conditions: Muscle Invasive Bladder Urothelial Carcinoma
Sponsor: IRCCS Eugenio Medea. Phase: . Conditions: Language Development, Language Development Disorders, Infant Development, Infant Developmental Assessment
Sponsor: Federal University of Vicosa. Phase: NA. Conditions: Depressive Symptoms, Physical Function, Executive Function, Resistance Training
Sponsor: Ma Zhe. Phase: . Conditions: Thyroid Cancer
Sponsor: Novartis Gene Therapies. Phase: PHASE3. Conditions: Spinal Muscular Atrophy Type I
Sponsor: Chonnam National University Hospital. Phase: NA. Conditions: Myocardial Infarction (MI), ST-Segment Elevation Myocardial Infarction(STEMI), NSTEMI - Non-ST-Segment Elevation Myocardial Infarction, AF - Atrial Fibrillation
Sponsor: Labbafinejad Medical Center. Phase: PHASE2. Conditions: Erectile Dysfunction, Erectile Dysfunction Associated With Type 2 Diabetes Mellitus, Erectile Dysfunction Due to Arterial Disease, Erectile Dysfunction Due to Arterial Insufficiency, Erectile Dysfunction Due to General Medical Condition, Erectile Dysfunction Due to Neuropathy
Sponsor: Ain Shams University. Phase: . Conditions: Multiparametric, Magnetic Resonance Imaging, Validation, Vesical Imaging Reporting and Data System (VI-RADS), Muscle Invasive Bladder Cancer
Sponsor: University of Virginia. Phase: NA. Conditions: Tuberculosis (TB), Undernutrition
Sponsor: University of Nebraska Lincoln. Phase: NA. Conditions: Obesity
Sponsor: Barcelona Institute for Global Health. Phase: NA. Conditions: Infectious Disease, Infections, Child, Only
Sponsor: Ankara University. Phase: . Conditions: Liver Cancer, Adult
Sponsor: Virginia Commonwealth University. Phase: NA. Conditions: Obesity, Adiposity
Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: PHASE2. Conditions: Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH)
Sponsor: Buck Institute for Research on Aging. Phase: NA. Conditions: Frail Elderly, Aging, Immune Function, Muscle Function
Sponsor: Istanbul University. Phase: NA. Conditions: Low Back Pain, Low Back Pain, Mechanical, Low Back Pain and Core Muscle, Core Stabilization Exercise Therapy
Sponsor: MapLight Therapeutics. Phase: PHASE2. Conditions: Schizophrenia
Sponsor: Ottawa Heart Institute Research Corporation. Phase: PHASE3. Conditions: Pericarditis
Sponsor: Cardiol Therapeutics Inc.. Phase: PHASE2. Conditions: COVID-19, Cardiovascular Diseases, Cardiovascular Risk Factor
Sponsor: Ankara Medipol University. Phase: . Conditions: Patellofemoral Pain, PFP
Sponsor: City of Hope Medical Center. Phase: PHASE2. Conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma, HER2-Negative Breast Carcinoma
Sponsor: Brown University. Phase: NA. Conditions: Smoking Cessation, Obesity and Obesity-related Medical Conditions
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Vestibular Diseases
Sponsor: Chongqing University Cancer Hospital. Phase: PHASE2. Conditions: Rectal Neoplasms, Rectal Adenocarcinoma
Sponsor: Addis Ababa University. Phase: NA. Conditions: Breast Neoplasms, Musculoskeletal Pain, Arthralgia, Musculoskeletal Diseases, Pain, Fatigue Syndrome, Chronic
Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Metastatic Sarcoma, Recurrent Sarcoma, Resectable Sarcoma
Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Healthy Control
Sponsor: Johnson & Johnson Enterprise Innovation Inc.. Phase: PHASE1. Conditions: Neoplasms
Sponsor: Takeda. Phase: PHASE1. Conditions: Non-Small Cell Lung Cancer
Sponsor: Kazuya Hosokawa. Phase: PHASE4. Conditions: Eisenmenger Syndrome, Pulmonary Arterial Hypertension of Congenital Heart Disease
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Blastoid Variant Mantle Cell Lymphoma, CCND1 Protein Overexpression, CD20 Positive, CD5 Positive, FCER2 Negative, Pleomorphic Variant Mantle Cell Lymphoma, Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma, t(11;14)(q13;q32)
Sponsor: Yan Fuxia. Phase: . Conditions: Delirium - Postoperative, Sleep Problems
Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia. Phase: PHASE2. Conditions: HIV